Phase I Dose Escalation Study of Gemcitabine plus Irinotecan in Advanced Solid Tumors

AIM: To determine the maximally tolerated dose (MTD), recommended phase II dose (RPTD) and toxicity profile of gemcitabine plus irinotecan combination. PATIENTS AND METHODS: Thirty-nine evaluable patients with advanced solid tumors were treated with gemcitabine (Gem) and irinotecan (Iri) on days 1,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dugan, Elizabeth, Truax, Roxanne, Meadows, Kellen L., Blobe, Gerard C., Morse, Michael A., Fernando, Nishan H., Gockerman, Jon P., Petros, William P., Hurwitz, Herbert I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103184/
https://ncbi.nlm.nih.gov/pubmed/20044630
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados